Seminar Overview

This seminar series will provide updates on the diagnosis and treatment of the dominant forms of viral hepatitis and explore the latest data on advancing liver disease, hepatocellular carcinoma, fatty liver disease and other hepatic conditions.

Location-specific faculty experts will deliver state-of-the-art material utilizing a curriculum that features lectures, case analysis, current clinical trial outcomes and progress reports on promising prevention approaches and emerging therapies.

The seminar will concentrate on key diseases of the liver and address the latest diagnosis, treatment, and care management approaches in a setting that stresses interactive learning, audience participation, and collaborative discussion.

The program will increase the number of clinicians educated in preventing, diagnosing, treating, and/or referring liver-disease patients for more advanced care. The goal of this CME activity is to limit future cases and improve the outcomes of those already infected. The live seminars will be delivered in a hybrid format that uses both live lectures and several web-based pre-readings and post-program modules. In this way, participants can earn 10 Category 1 CME Credits™ while spending just one day in the classroom.

Available in two formats

A live, face-to-face seminar
A web-based, self-paced activity

ALL Versions are approved for CME credit

Dates and Locations

March 2, 2024 - Louisville, KY
March 16, 2024 - Chicago, IL
March 23, 2024 - Durham, NC
April 13, 2024 - Costa Mesa, CA
April 27, 2024 - Miami, FL
May 4, 2024 - Seattle, WA
September 7, 2024 - Atlanta, GA
September 21, 2024 - Cincinnati, OH
October 5, 2024 - Pasadena, CA
This year's web-based, self-paced Enduring Material is now available.

Agenda